Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.

NCT00359489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2007-09-17

No results posted yet for this study

Summary

Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.

Conditions

  • Heart Valve Diseases

Interventions

DEVICE

cardiac echosonography

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00359489 on ClinicalTrials.gov